Literature DB >> 7777019

Protecting the embryo from X-rated drugs.

J L Mills.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7777019     DOI： 10.1056/NEJM199507133330211

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Post-marketing surveillance should include effects during pregnancy.

Authors:  Patricia Yeargin
Journal:  BMJ       Date:  2005-02-05

2.  Drugs and the fetus.

Authors:  P Vallance
Journal:  BMJ       Date:  1996-04-27

3.  Efavirenz use during pregnancy and for women of child-bearing potential.

Authors:  Matthew F Chersich; Michael F Urban; Francois W D Venter; Tina Wessels; Amanda Krause; Glenda E Gray; Stanley Luchters; Dennis L Viljoen
Journal:  AIDS Res Ther       Date:  2006-04-07       Impact factor: 2.250
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.